A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy - Contacts and Locations

Home

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

This study has been completed.

Study NCT00069888. Last updated on July 21, 2008. Information provided by Sanofi-Aventis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00069888

Locations


United States, New Jersey
	Sanofi-Aventis US
	Bridgewater, New Jersey, United States, 08807

Sponsors and Collaborators

Sanofi-Aventis

Investigators


Study Director:	Yasir Nagarwala, M.D.	Sanofi-Aventis